Search

Search Language

English | Use language selector above (below, on mobile) to search additional languages

Open filter

16 items matching filters

Search Results

Client Result

Carlyle and SK Capital to Acquire bluebird bio

1 minute read | March.07.2025

bluebird bio announced it will be acquired in a take private transaction by Beacon Parent Holdings, collaborating with Carlyle Group and SK Capital.

Client Result

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. to Combine to Form Dogwood Therapeutics, Inc.

2 minute read | October.07.2024

Virios Therapeutics plans to combine with Wex Pharmaceuticals in an all-stock transaction to form a combined company called Dogwood Therapeutics.

Client Result

Education Technology D2L Acquires H5P

2 minute read | July.10.2024

D2L Inc., a global learning technology company is acquiring H5P Group, a leading provider of interactive content-creation software.

Client Result

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc.

2 minute read | April.10.2024

Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.

Client Result

TotalEnergies Acquires 1.5 GW Flexible Power Generation Capacity in Texas

1 minute read | November.16.2023

TotalEnergies has signed an agreement with TexGen to acquire for $635 million three gas-fired power plants with a total capacity of 1.5 GW in Texas.

Client Result

Ferring Pharmaceuticals Enters Royalty Agreement for Bladder Cancer Gene Therapy

2 minute read | August.28.2023

Ferring Pharmaceuticals and Royalty Pharma have entered into a royalty agreement for sales of Ferring’s new gene therapy for bladder cancer.

Client Result

‘Truly Transformational:’ Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China)

2 minute read | July.20.2023

Sosei Heptares has announced its acquisition of Idorsia’s pharmaceuticals business in Japan and APAC (ex-China). Orrick advised Sosei Heptares.

Client Result

Orrick Advises RapidMiner on $100 Million Acquisition by Altair

September.19.2022

Congratulations to our client RapidMiner, a data analytics and machine learning software company, on its acquisition by Altair Engineering.

Client Result

Orrick Advised Catalyst Biosciences on $60 Million Sale of Complement Portfolio

May.24.2022

Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.

Client Result

Orrick Advises Qualifacts+Credible on its Acquisition of InSync Healthcare Solutions

December.20.2021

Orrick has advised Qualifacts+Credible, a leading provider of electronic health record platforms, on its add-on acquisition of InSync Healthcare ...

Client Result

Orrick Advises Apex Clean Energy in Sale of Majority Stake to Ares

October.07.2021

Orrick advised Apex Clean Energy in the sale of a majority stake in the company to funds and other accounts managed by Ares Management.

Client Result

Orrick Advises Aria Energy on SPAC Merger With Archaea Energy and Rice Acquisition Corp.

September.16.2021

Orrick advised Aria Energy on its business combination with Archaea Energy and special purpose acquisition company Rice Acquisition Corporation ...